(S)-4-(5-amino-6-(3-methyl-5-oxo-2,3,4,5-tetrahydro-1H-benzo[e][1,4]diazepin-8-yl)pyrazin-2-yl)-N-cyclopropyl-N-methylbenzenesulfonamide | 1396775-51-1

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 苯二氮卓类
• 英文名称: (S)-4-(5-amino-6-(3-methyl-5-oxo-2,3,4,5-tetrahydro-1H-benzo[e][1,4]diazepin-8-yl)pyrazin-2-yl)-N-cyclopropyl-N-methylbenzenesulfonamide
• 英文别名: 4-[5-amino-6-[(3S)-3-methyl-5-oxo-1,2,3,4-tetrahydro-1,4-benzodiazepin-8-yl]pyrazin-2-yl]-N-cyclopropyl-N-methylbenzenesulfonamide
• CAS: 1396775-51-1
• 化学式: C₂₄H₂₆N₆O₃S
• 分子量: 478.575
• InChiKey: VKCYSWUPOHITAN-AWEZNQCLSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  1.9
• 重原子数：
  34
• 可旋转键数：
  5
• 环数：
  5.0
• sp3杂化的碳原子比例：
  0.29
• 拓扑面积：
  139
• 氢给体数：
  3
• 氢受体数：
  8

文献信息

• MST1 KINASE INHIBITORS AND METHODS OF THEIR USE
  申请人：Lexicon Pharmaceuticals, Inc.

  公开号：EP2681206A1

  公开（公告）日：2014-01-08
• [EN] MST1 KINASE INHIBITORS AND METHODS OF THEIR USE<br/>[FR] INHIBITEURS DE KINASE MST1 LEURS PROCÉDÉS D'UTILISATION
  申请人：LEXICON PHARMACEUTICALS INC

  公开号：WO2012121992A1

  公开（公告）日：2012-09-13

  Compounds for the inhibition of mammalian Ste20-like kinase 1 (MST1) are disclosed, along with compositions comprising them and methods of their use in the treatment, management or prevention of an inflammatory or autoimmune diseases or disorders.